These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 17008229)

  • 21. Initial antibiotic selection and patient outcomes: observations from the National Pneumonia Project.
    Bratzler DW; Ma A; Nsa W
    Clin Infect Dis; 2008 Dec; 47 Suppl 3():S193-201. PubMed ID: 18986289
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improving outcomes in elderly patients with community-acquired pneumonia by adhering to national guidelines: Community-Acquired Pneumonia Organization International cohort study results.
    Arnold FW; LaJoie AS; Brock GN; Peyrani P; Rello J; Menéndez R; Lopardo G; Torres A; Rossi P; Ramirez JA;
    Arch Intern Med; 2009 Sep; 169(16):1515-24. PubMed ID: 19752410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A prediction rule for estimating the risk of bacteremia in patients with community-acquired pneumonia.
    Falguera M; Trujillano J; Caro S; Menéndez R; Carratalà J; Ruiz-González A; Vilà M; García M; Porcel JM; Torres A;
    Clin Infect Dis; 2009 Aug; 49(3):409-16. PubMed ID: 19555286
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Validation of the Infectious Diseases Society of America/American Thoracic Society criteria to predict severe community-acquired pneumonia caused by Streptococcus pneumoniae.
    Kontou P; Kuti JL; Nicolau DP
    Am J Emerg Med; 2009 Oct; 27(8):968-74. PubMed ID: 19857416
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Propensity score adjustment for pretreatment differences between hospitalized and ambulatory patients with community-acquired pneumonia. Pneumonia Patient Outcomes Research Team (PORT) Investigators.
    Stone RA; Obrosky DS; Singer DE; Kapoor WN; Fine MJ
    Med Care; 1995 Apr; 33(4 Suppl):AS56-66. PubMed ID: 7723462
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patterns of resolution of chest radiograph abnormalities in adults hospitalized with severe community-acquired pneumonia.
    Bruns AH; Oosterheert JJ; Prokop M; Lammers JW; Hak E; Hoepelman AI
    Clin Infect Dis; 2007 Oct; 45(8):983-91. PubMed ID: 17879912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of levofloxacin and moxifloxacin use in hospitalized community-acquired pneumonia (CAP) patients in the US: focus on length of stay.
    Schein J; Janagap-Benson C; Grant R; Sikirica V; Doshi D; Olson W
    Curr Med Res Opin; 2008 Mar; 24(3):895-906. PubMed ID: 18419876
    [TBL] [Abstract][Full Text] [Related]  

  • 28. C-reactive protein is an independent predictor of severity in community-acquired pneumonia.
    Chalmers JD; Singanayagam A; Hill AT
    Am J Med; 2008 Mar; 121(3):219-25. PubMed ID: 18328306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identifying severe community-acquired pneumonia in the emergency department: a simple clinical prediction tool.
    Buising KL; Thursky KA; Black JF; MacGregor L; Street AC; Kennedy MP; Brown GV
    Emerg Med Australas; 2007 Oct; 19(5):418-26. PubMed ID: 17919214
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A prospective investigation of outcomes after hospital discharge for endemic, community-acquired methicillin-resistant and -susceptible Staphylococcus aureus skin infection.
    Miller LG; Quan C; Shay A; Mostafaie K; Bharadwa K; Tan N; Matayoshi K; Cronin J; Tan J; Tagudar G; Bayer AS
    Clin Infect Dis; 2007 Feb; 44(4):483-92. PubMed ID: 17243049
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Community-acquired pneumonia in patients with and without chronic obstructive pulmonary disease.
    Molinos L; Clemente MG; Miranda B; Alvarez C; del Busto B; Cocina BR; Alvarez F; Gorostidi J; Orejas C;
    J Infect; 2009 Jun; 58(6):417-24. PubMed ID: 19329187
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of standardized order sets and intensive clinical case management on outcomes in community-acquired pneumonia.
    Fishbane S; Niederman MS; Daly C; Magin A; Kawabata M; de Corla-Souza A; Choudhery I; Brody G; Gaffney M; Pollack S; Parker S
    Arch Intern Med; 2007 Aug 13-27; 167(15):1664-9. PubMed ID: 17698690
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictors of mortality after discharge in patients hospitalized with heart failure: an analysis from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).
    O'Connor CM; Abraham WT; Albert NM; Clare R; Gattis Stough W; Gheorghiade M; Greenberg BH; Yancy CW; Young JB; Fonarow GC
    Am Heart J; 2008 Oct; 156(4):662-73. PubMed ID: 18926148
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Routine use of the Pneumonia Severity Index for guiding the site-of-treatment decision of patients with pneumonia in the emergency department: a multicenter, prospective, observational, controlled cohort study.
    Renaud B; Coma E; Labarere J; Hayon J; Roy PM; Boureaux H; Moritz F; Cibien JF; Guérin T; Carré E; Lafontaine A; Bertrand MP; Santin A; Brun-Buisson C; Fine MJ; Roupie E;
    Clin Infect Dis; 2007 Jan; 44(1):41-9. PubMed ID: 17143813
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Community-acquired pneumonia in older patients: does age influence systemic cytokine levels in community-acquired pneumonia?
    Kelly E; MacRedmond RE; Cullen G; Greene CM; McElvaney NG; O'Neill SJ
    Respirology; 2009 Mar; 14(2):210-6. PubMed ID: 19272082
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A teaching hospital's experience applying the Pneumonia Severity Index and antibiotic guidelines in the management of community-acquired pneumonia.
    Lee RW; Lindstrom ST
    Respirology; 2007 Sep; 12(5):754-8. PubMed ID: 17875067
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gemifloxacin once daily for 5 days versus 7 days for the treatment of community-acquired pneumonia: a randomized, multicentre, double-blind study.
    File TM; Mandell LA; Tillotson G; Kostov K; Georgiev O
    J Antimicrob Chemother; 2007 Jul; 60(1):112-20. PubMed ID: 17537866
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Empiric treatment in hospitalized community-acquired pneumonia. Impact on mortality, length of stay and re-admission.
    Reyes Calzada S; Martínez Tomas R; Cremades Romero MJ; Martínez Moragón E; Soler Cataluña JJ; Menéndez Villanueva R
    Respir Med; 2007 Sep; 101(9):1909-15. PubMed ID: 17628462
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence-based emergency medicine/critically appraised topic. Evidence behind the 4-hour rule for initiation of antibiotic therapy in community-acquired pneumonia.
    Yu KT; Wyer PC
    Ann Emerg Med; 2008 May; 51(5):651-62, 662.e1-2. PubMed ID: 18272253
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Validation and clinical implications of the IDSA/ATS minor criteria for severe community-acquired pneumonia.
    Phua J; See KC; Chan YH; Widjaja LS; Aung NW; Ngerng WJ; Lim TK
    Thorax; 2009 Jul; 64(7):598-603. PubMed ID: 19386583
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.